Renal vein thrombosis and selective arterial or venous thrombolytic therapy

Summary Background: Renal vein thrombosis (RVT) complicating the nephrotic syndrome is associated with a poor prognosis. Methods/Results: RVT was diagnosed in 12 of 60 patients with a diagnosis of nephrotic syndrome suggested by computed tomography (CT) and subsequently confirmed by selective renal angiography. Fifty patients carried a diagnosis of primary glomerulonephritis with various pathological findings, and 10 patients had lupus nephritis. Renal vein and peripheral vein blood samples were collected in the 12 patients with RVT and were assayed for fibrin(ogen) degradation products (FDP), antithrombin III (AT III), VIIIR:AG, and fibrinogen. The results suggested a state of hypercoagulation. Of these 12 patients, 7 were given 200,000 units of urokinase (UK) over 60 minutes in divided doses selectively via the renal vein. Five patients were given 200,000 units UK selectively into the renal artery. All patients also received 2.5 mg/day warfarin and 75 mg/day persantine. Except for three patients with focal glomerulosclerosis, all patients received 40 mg/day prednisone. After 1 month, the CT scan and blood samples for FDP, AT III, VIIIR:AG, and fibrinogen were repeated. Patients receiving intra-arterial UK had complete resolution of their thrombi. Complete resolution was also suggested in 2 of the 7 patients receiving UK by renal vein, and there was partial resolution in the other five. The hypercoagulation state decreased in all patients. Conclusions: We conclude that RVT is not an uncommon event in patients with nephrotic syndrome. The diagnosis can be supported reliably using abdominal CT scanning. Although a small number of patients were included in this nonrandomized study, it appeared that intra-arterial thrombolytic therapy yielded better results. The patients with minimal change disease have a good prognosis.     

.MYCOLOGIC IDENTIFICATION OF EMERICELLA NIDULANS AND ASPERGILLUS FLAVUS CAUSED PULMONARY INFECTION

A rare case of pulmonary infection caused by Emericella nidulans and Aspergillus flavus is reported for the first time in our country. "This diagnosis is of significance mycologically. :Direct microscopic examination and histopatho- logic cross section of expectorated mass show numerolus cleistoithecia of varying size, filled by asci and ascospores. Outside the cleistothecia 'were numerous thickwalled Hulle cells. The pa- tient was treated satisfactorily with antimyco- tics.     

“坤月安”治疗经前期综合征的临床观察

38例经前期综合征患者,经基础体温测定或宫内膜活检。诊断为黄体功能不健33例（86．89％）,无排卵月经周期5例。其中原发不孕5例,继发不孕19例,均有典型的经前期综合征症状。其中30例用自行研制的中药“坤月安”冲剂治疗。每次服坤月安1所,每日2次,于月经来潮前10天开始服用,10天为一疗程,均服用3个疗程,痊愈10例（33．43％）,显效13例（43．33％）,好转6例（20％）,无效1例（3．33％）,总有效率96．67％。     

恙虫病63例临床分析

目的 为了进一步了解恙虫病的临床特点。方法 对63例恙虫病的临床资料进行回顾性分析。结果 所有病例均有持续较长时间的发热并伴不同程度的毒血症，出现焦痂溃疡60例(95％)，淋巴结肿大40例(63％)，皮疹32例(51％)，两个以上脏器损害48例(76％)，多器官功能衰竭7例(11％)；白细胞计数正常或偏低者占70％。及时使用特效抗生素治疗有良效。结论 著虫病的临床表现多样化，早期诊断和及时治疗对预后十分重要。     

神阙穴贴药对原发性骨质疏松症超声穿透速度的影响

目的：观察神阙穴贴补血益精透皮贴剂，对原发性骨质疏松症超声穿透速度（SOS）的影响。方法：选择原发性骨质疏松症患者130例。分4组治疗。即补血益精透皮贴剂组（A组），西药对照组（B组），补血益精药丸组（C组），空白对照组（D组）。结果：补血益精透皮贴剂组能显著提高超声穿透速度。结论：补血益精透皮贴剂组与补血益精药丸组和西药对照组对原发性骨质疏松症的调整作用基本一致。为治疗原发性骨质疏松症提供了一种新的方法。     

口腔愈疡颗粒质量标准的建立

目的：建立口腔愈疡颗粒的质量标准。方法：采用高效液相色谱法对成品中芍药苷进行含量测定。结果：芍药香浓度线性范围为：0．104—0．520μg/ml,γ=0.9993。样品平均回收率为98．85％，RSD为1．27％(n＝5)。结论：该方法适用于口腔愈疡颗粒的质量控制。     

充血性心力衰竭心气、阳虚证与肿瘤坏死因子-α、白细胞介素-1β和白细胞介素-10的关系

目的:探讨充血性心力衰竭(CHF)患者心气、阳虚证与肿瘤坏死因子-α(TNF-α)、白细胞介素-1β(IL-1β)及白细胞介素-10(IL-10)的关系。方法:选取CHF心气、阳虚证住院患者67名,分别进行NYHA心功能分级,并行心脏多普勒、血清TNF-α、IL-1β及IL-10等检查。结果:心气虚证组患者心功能分级以舒张功能不全和心功能Ⅰ级、Ⅱ级为多,心阳虚证组患者以心功能Ⅲ级、Ⅳ级为多(Ridit分析,P<0.01);心气虚证组患者E/A值、EF值高于心阳虚证组(P<0.01);心阳虚证组患者血清TNF-α、IL-1β水平高于心气虚证组(P<0.01或P<0.05);心阳虚证组患者血清IL-10水平低于心气虚证组(P<0.01)。结论:TNF-α、IL-1β与IL-10可能在CHF心气虚证向心阳虚证发展过程中起重要的作用,可以作为心气虚证、心阳虚证微观辨证的指标。     

经尿道前列腺汽化与开放性手术对老年前列腺增生患者术后性功能的影响

目的评价经尿道前列腺汽化(TUVP)和开放性手术对老年前列腺增生(BPH)患者术后性功能的影响.方法分别统计分析经尿道前列腺汽化组(TUVP组)、耻骨上经膀胱前列腺切除组(SPP组)和耻骨后保留尿道前列腺切除组(Madigan组)术后6个月、1 2个月勃起障碍(ED)与逆行射精(RE)的发生率.结果术后6个月ED的发生率在TUVP组(n=52)、SPP组(n=46)、Madigan组(n=32)分别为1 3.4%(7/52)、1 5.2%(7/46)、1 2.5%(4/32),术后12个月ED的发生率分别为11.5%(6/52)、1 5.2%(7/46)、1 2.5%(4/32),术后6个月、1 2个月RE的发生率在TUVP组、SPP组、Madigan组分别为46.2%(24/5 2)、39.1%(1 8/46)、9.3%(3/32).结论TUVP与传统开放性手术SPP及Madigan手术相比较对勃起障碍的影响无统计学差异(p＞0.05),但逆行射精的发生率较Madigan手术组高,提示对术后射精功能有较大影响.     

雌孕激素合用对去卵巢大鼠骨质疏松的预防作用

目的　观察炔诺酮和炔雌醇联合应用对去卵巢大鼠骨质疏松的预防作用。方法　 4个半月龄大鼠双侧卵巢去除术后预防用药 90d。用骨组织形态计量学方法 ,测定大鼠胫骨近端松质骨静态参数和动态参数 ,观察骨和尿中有机质和无机质的含量 ,血清生化指标和器官指数。结果　炔诺酮6 0 μg·kg-1·d-1和炔雌醇 3 5 μg·kg-1·d-1联合应用可抑制去卵巢大鼠的破骨细胞活性 ,完全对抗其骨转化率增高和骨量丢失的骨质疏松症状 ,同时可使去卵巢大鼠的骨有机质含量增加和尿羟脯氨酸排出量减少。结论　炔诺酮和炔雌醇联合应用可预防去卵巢大鼠骨质疏松     

人前列腺癌细胞PC-3M亚系u-PAR基因表达的分析

目的 为研究与人前列腺癌细胞(PC-3M)侵袭能力相关的靶分子。方法 采用有限稀释法分离单克隆细胞株，并应用单层细胞侵袭等实验鉴定各亚系的体外侵袭能力；借助RT-PCR和免疫组化的方法，分别在转录和翻译水平检测5株侵袭能力不同的PC-3M亚系尿激酶型纤溶酶原激活物受体(u-PAR)的表达。结果 高侵袭亚系u-PAR基因mRNA的表达和蛋白质水平均明显高于低侵袭亚系。结论 PC-3M亚系u-PAR的高表达与其较强的侵袭能力密切相关，而u-PAR可能是抑制高侵袭亚系侵袭效应的一个重要靶分子。